FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer is a research paper published in Cancer Cell (2020). On theSindex it has a DataRank of 0.742. It has been cited 140 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.742
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Glaucoma Research Foundation
Grant: 06174006
NCI NIH HHS
Grant: K00 CA212478
National Institutes of Health
Grant: P30 CA008748
National Institutes of Health
Grant: RO1CA190642-01A1
National Natural Science Foundation of China
Grant: 31771454
Glaucoma Research Foundation
Grant: 17128918
NCI NIH HHS
Grant: R01 CA190642
National Science Foundation
Procter and Gamble
Prostate Cancer Foundation
Stand Up To Cancer
AstraZeneca
Roche
Breast Cancer Alliance
Weill Cornell Medical College
Genentech
Breast Cancer Research Foundation
Geoffrey Beene Cancer Research Center
Novartis
MeSH Terms
Keywords
Additional file 1 of Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
Additional file 1 of Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
Additional file 4 of Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
Additional file 4 of Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
Additional file 5 of Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
Additional file 5 of Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
Additional file 6 of Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
Additional file 6 of Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
Additional file 3 of Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
Additional file 2 of Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
Additional file 3 of Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
Additional file 2 of Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial